title: Analysis of pharmaceutical product diversion and the gray market: cheaper drugs, but at what cost?
authors.affiliation: McGuireWoods LLP, Charlotte, North Carolina, USA. kdooley@mcguirewoods.com
authors.forename: Kathleen
authors.initials: K
authors.lastname: Dooley
authors.forename: Julie Ann
authors.initials: JA
authors.lastname: Sullivan
mesh_terms: D003132:Commerce; D058110:Counterfeit Drugs; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D004364:Pharmaceutical Preparations / Q000191:economics* / Q000592:standards; D014481:United States
chemical_list: D058110:Counterfeit Drugs; D004364:Pharmaceutical Preparations